Skip to main content
. 2023 Jan 9;12:1024179. doi: 10.3389/fonc.2022.1024179

Table 3.

The top 10 journals with most citations per paper per year in melanoma immunotherapy between 2010 and 2022.

Journals with most papers Paper number Top-Paper number TPR (2010-2020) a Total citation Citation per paper Citation per paper per year b Local citation c IF (2020)
N. Engl. J. Med. 17 16 100.0% 42682 2510.7 356.9 6181 91.25
Science 6 3 100.0% 4520 753.3 202 1180 47.73
Nature 3 1 33.3% 751 250.3 112.7 1566 49.96
Lancet 4 2 50.0% 2171 542.8 102.3 690 79.32
Cell 5 3 60.0% 2481 496.2 100.1 968 41.58
Lancet Oncol. 25 14 70.0% 9784 391.4 72.8 2050 41.32
J. Exp. Med. 3 3 100.0% 2262 754 71 894 14.31
JAMA 2 1 50.0% 710 355 57.8 234 56.27
Sci. Transl. Med. 7 3 42.9% 2160 308.6 45.9 405 17.99
JAMA Oncol. 8 1 16.7% 1085 135.6 44.1 450 31.78
a

Percentage of top-cited papers among all papers in a journal. The time span was from 2010 to 2020 (the year of publication of the most recent top-cited paper.

b

Papers published in 2022 were not included for calculating citation per paper per year.

c

Citation number in the current dataset (papers in melanoma immunotherapy between 2010 and 2022).